Biologic therapy in HS shows dual benefits: improved skin lesions and potential systemic anti-inflammatory effects, as indicated by lipid profile changes. Early treatment initiation is crucial for ...

This article is authored by Ravi Gupta, SVP, CitiusTech.

Real world data is transforming clinical research, augmenting existing randomized controlled trial data to reduce risks and improve generalizability. With regulators setting clearer standards for ...

The European Medicines Agency (EMA) uses Data Analysis and Real-World Interrogation Network (DARWIN EU), a data network that became fully operational in 2024, to generate real-world evidence on ...

Blood-based multi-cancer early detection (MCED) has the potential to simultaneously screen for multiple deadly cancers with high positive predictive value. To assess real-world performance, we ...

The majority of patients with early-stage disease Alzheimer’s disease (AD) had stable or improved cognition over roughly 1 year of treatment with lecanemab (Leqembi), a real-world analysis showed. The ...

Artificial intelligence (AI) holds promise for healthcare, but real-world implementation remains difficult. The Mayo clinic platform (MCP) addresses this by providing scalable, multi-institutional, de ...

Why is tokenization important for the future of medicine development? A tremendous amount of data is collected throughout a clinical trial, but prior to tokenization, the life science industry did not ...